Understanding and Managing Atopic Dermatitis in Adult Patients

Seminars in Cutaneous Medicine and Surgery

Volumn 31, Issue 3 SUPPL., 2012, Pages

  Ellis, Charles N ^a   Mancini, Anthony J ^b,e   Paller, Amy S ^b,e   Simpson, Eric L ^c   Eichenfield, Lawrence F ^d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Atopic dermatitis, adults; Depression; Dermatologic infections; Pruritus; Topical anti inflammatories

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN; FATTY ACID; FILAGGRIN; GAMMA INTERFERON; HOUSE DUST ALLERGEN; METHOTREXATE; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROBIOTIC AGENT; TACROLIMUS;

ADOLESCENT; ADULT; ADULTHOOD; AGED; ALLERGIC REACTION; ALOPECIA AREATA; ATOPIC DERMATITIS; ATTENTION DEFICIT DISORDER; AUTISM; BACTERIAL COLONIZATION; CHILD; CHILDHOOD; CHRONIC IDIOPATHIC URTICARIA; CLINICAL FEATURE; COMORBIDITY; CYTOKINE PRODUCTION; DEPRESSION; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; DRUG EFFICACY; GENE DOSAGE; GENE MAPPING; GENETIC ASSOCIATION; HERPES SIMPLEX; HOUSE DUST ALLERGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KAPOSI VARICELLIFORM ERUPTION; LOSS OF FUNCTION MUTATION; MALASSEZIA; ONSET AGE; PARANOIA; PATIENT EDUCATION; PHOBIA; PHOTOTHERAPY; PRESCHOOL CHILD; PRURITUS; PSORIASIS; PSYCHOSEXUAL DISORDER; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SKIN INFECTION; SOMATIZATION; STAPHYLOCOCCUS AUREUS; SUICIDAL IDEATION; TH2 CELL; URTICARIA;

ADULT; AGE OF ONSET; AGED; COMORBIDITY; COMPREHENSION; DEPRESSION; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; HUMANS; INTERPERSONAL RELATIONS; MIDDLE AGED; QUALITY OF LIFE;

EID: 84866863667     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.1016/j.sder.2012.07.006     Document Type: Review

References (38)

1. Schmitt J., Bauer A., Meurer M. Atopic eczema in adulthood. Hautarzt 2008, 59:841-852. [in German].
2. Tanei R. Atopic dermatitis in the elderly. Inflamm Allergy Drug Targets 2009, 8:398-404.
3. Wolkewitz M., Rothenbacher D., Low M., et al. Lifetime prevalence of self-reported atopic diseases in a population-based sample of elderly subjects: Results of the ESTHER study. Br J Dermatol 2007, 156:693-697.
4. van den Oord R.A., Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: Systematic review and meta-analysis. BMJ 2009, 339:b2433.
5. Brown S.J., Kroboth K., Sandilands A., et al. Intragenic copy number variation with filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect. J Invest Dermatol 2012, 132:98-104.
6. Bannister M.J., Freeman S. Adult-onset dermatitis. Australas J Dermatol 2000, 41:225-228.
7. Ozkaya E. Adult-onset atopic dermatitis. J Am Acad Dermatol 2005, 52:579-582.
8. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980, 92:44-47.
9. Leung D.Y.M., Boguniewicz M., Howell M.D., et al. New insights into atopic dermatitis. J Clin Invest 2004, 113:651-657.
10. Bozek A., Fisher A., Filipowska B., et al. Clinical features and immunological markers of atopic dermatitis in elderly patients. Int Arch Allergy Immunol 2012, 157:372-378.
11. Gilani S.J., Gonzalez M., Hussain I., et al. Staphylococcus aureus re-colonization in atopic dermatitis: Beyond the skin. Clin Exp Dermatol 2005, 30:10-13.
12. Roll A., Cozzio A., Fischer B., et al. Microbial colonization and atopic dermatitis. Curr Opin Allergy Clin Immunol 2004, 4:373-378.
13. Sandström M.H., Faergemann J. Prognosis and prognostic factors in adult patients with atopic dermatitis: A long-term follow-up questionnaire study. Br J Dermatol 2004, 150:103-110.
14. Sandström Falk M.H., Faergemann J. Atopic dermatitis in adults: Does it disappear with age?. Acta Derm Venereol 2006, 86:135-139.
15. Leung D.Y.M., Gao P.-S., Grigoryev D.N., et al. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response. J Allergy Clin Immunol 2011, 127:965-973.
16. Fried R.G., Gupta M.A., Gupta A.K. Depression and skin disease. Dermatol Clin 2005, 23:657-664.
17. Gupta M.A., Gupta A.K., Schork N.J., et al. Depression modulates pruritus perception: A study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994, 56:36-40.
18. Kimata H. Prevalence of suicidal ideation in patients with atopic dermatitis. Suicide Life Threat Behav 2006, 36:120-124.
19. Zuberbier T., Orlow S.J., Paller A.S., et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 2006, 118:226-232.
20. Rehal B., Armstrong A.W. Health outcomes in atopic dermatitis. Dermatol Clin 2012, 30:73-86.
21. Kiebert G., Sorensen S.V., Revicki D., et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002, 41:151-158.
22. Haeck I.M., ten Berge O., van Velsen S.G.A., et al. Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2012, 26:236-241.
23. Kelsay K., Klinnert M., Bender B. Addressing psychosocial aspects of atopic dermatitis. Immunol Allergy Clin North Am 2010, 30:385-396.
24. Paller A.S., Eichenfield L.E., Ellis C., et al. Treatment strategies for atopic dermatitis: Optimizing the available therapeutic options. Semin Cutan Med 2012, 31(suppl):S10-S17.
25. Callen J., Chamlin S., Eichenfield L.F., et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol 2007, 156:203-221.
26. Gisondi P., Ellis C.N., Girolomoni G. Pimecrolimus in dermatology: Atopic dermatitis and beyond. Int J Clin Pract 2005, 59:969-974.
27. Reynolds N.J., Franklin V., Gray J.C., et al. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: A randomised controlled trial. Lancet 2001, 357:2012-2016.
28. Majoie I.M., Oldhoff J.M., van Weelden H., et al. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 2009, 60:77-84.
29. Gambichler T., Othlinghaus N., Tomi N.S., et al. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: A randomized crossover study. Br J Dermatol 2009, 160:652-658.
30. Krathen R.A., Hsu S. Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol 2005, 53:338-340.
31. Vigo P.G., Girgis K.R., Pfuetze B.L., et al. Efficacy of anti-IgE therapy in patients with atopic dermatitis. J Am Acad Dermatol 2006, 55:168-170.
32. Jung T., Stingl G. Atopic dermatitis: Therapeutic concepts evolving from new pathophysiologic insights. J Allergy Clin Immunol 2008, 122:1074-1081.
33. Veien N.K., Busch-Sorensen M., Stausbøl-Gron B. Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2005, 53:147-149.
34. Friedmann P.S., Palmer R., Tan E., et al. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema. Clin Exp Allergy 2007, 37:1536-1540.
35. Stainer R., Matthews S., Arshad S.H., et al. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: A double-blind, randomized, placebo-controlled trial. Br J Dermatol 2005, 152:334-341.
36. van der Aa L.B., Heymans H.S., van Aalderen W.M., et al. Probiotics and prebiotics in atopic dermatitis: Review of the theoretical background and clinical evidence. Pediatr Allergy Immunol 2010, 21:e355-e367.
37. van Gool C.J., Zeegers M.P., Thijs C. Oral essential fatty acid supplementation in atopic dermatitis-a meta-analysis of placebo-controlled trials. Br J Dermatol 2004, 150:728-740.
38. Zhang W., Leonard T., Bath-Hextall F., et al. Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev 2004, CD002291.